Abstract 1771: Phase 3 trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: exploratory molecular analysis of tumor biomarkers
Year: 2017
Type: conference-abstract
Source: Cancer Research
Authors: Daniel J. George, Jean-Francois Martini, Yen-Hwa Chang, Michael Staehler, Jan Breza, Jean-Jacques Patard, Robert J. Motzer, Ahmed Magheli, Bernard Escudier, Giacomo Carteni, Paola Gerletti, Sherry Li, Michelle Casey, Brigitte Laguerre, Hardev S. Pandha, Allan J. Pantuck, Anup Patel, Maria Lechuga, Alain Ravaud
Institutions: Duke Cancer Institute, Pfizer (United States), Taipei Veterans General Hospital, München Klinik, Slovak Medical University, Bicêtre Hospital, Memorial Sloan Kettering Cancer Center, Stiftung Charité, Charité – Universitätsmedizin Berlin, Institut Gustave Roussy, Ospedale Antonio Cardarelli, Pfizer (Italy), Centre Eugène Marquis, University of Surrey, Ronald Reagan UCLA Medical Center, UCLA Medical Center, Spire London East Hospital, Centre Hospitalier Universitaire de Bordeaux
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2741735300